3 ML heparin sodium, porcine 1000 UNT/ML / taurolidine 13.5 MG/ML Injection — RxCUI 2670461
RxNorm drug concept · Semantic clinical drug
RxCUI 2670461
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2670461
Official name3 ML heparin sodium, porcine 1000 UNT/ML / taurolidine 13.5 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asheparin sodium, porcine 3,000 UNT / taurolidine 40.5 MG per 3 ML Injection; heparin sodium, porcine 3,000 UNT / taurolidine 40.5 MG in 3 ML Injection
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)1,550 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Heparin Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Heparin works almost instantly when given into a vein, which makes it ideal for serious or urgent clotting situations — like a blood clot in the lungs, during surgery, or on dialys...
- Why do I need heparin? Can't I just take a blood thinner pill?
- Bleeding is the main concern with heparin. Watch for things like nosebleeds that won't stop, blood in your urine, black or tarry stools, unusual bruising, or any severe pain that c...
- What side effect should I be most worried about?
🕸️ Concept Web — How 3 ML heparin sodium, porcine 1000 UNT/ML / tauro... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
3 ML heparin sodium, porcine 1000 UNT/ML / taurolidine 13.5 MG/ML Injection
RxCUI 2670461 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Heparin
5224IN -
Taurolidine
2670453IN -
Heparin / taurolidine
2670456MIN -
Heparin sodium, porcine
314659PIN
-
Heparin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Defencath
2670463BN
-
Defencath
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Heparin / taurolidine Injection
2670458SCDF -
Heparin sodium, porcine / taurolidine Injection
2670460SCDFP -
Heparin / taurolidine Injectable Product
2670457SCDG -
Heparin sodium, porcine / taurolidine Injectable Product
2670459SCDGP -
Heparin / taurolidine Injection [Defencath]
2670466SBDF -
Heparin sodium, porcine / taurolidine Injection [Defencath]
2670467SBDFP -
Defencath Injectable Product
2670465SBDG -
Injection
1649574DF - +1 more in this family
-
Heparin / taurolidine Injection
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Heparin sodium, porcine 1000 UNT/ML
1361225SCDC -
Taurolidine 13.5 MG/ML
2670455SCDC -
3 ML heparin sodium, porcine 1000 UNT/ML / taurolidine 13.5 MG/ML Injection [Defencath]
2670468SBD -
Heparin sodium, porcine 1000 UNT/ML / taurolidine 13.5 MG/ML [Defencath]
2670464SBDC
-
Heparin sodium, porcine 1000 UNT/ML
Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Heparin sodium, porcine 1000 UNT/ML
SCDC · 1361225 -
Taurolidine 13.5 MG/ML
SCDC · 2670455 -
Heparin / taurolidine Injection
SCDF · 2670458 -
Heparin sodium, porcine / taurolidine Injection
SCDFP · 2670460 -
Heparin / taurolidine Injectable Product
SCDG · 2670457 -
Heparin sodium, porcine / taurolidine Injectable Product
SCDGP · 2670459
Brand-Name Concepts
-
3 ML heparin sodium, porcine 1000 UNT/ML / taurolidine 13.5 MG/ML Injection [Defencath]
SBD · 2670468 -
Heparin sodium, porcine 1000 UNT/ML / taurolidine 13.5 MG/ML [Defencath]
SBDC · 2670464 -
Heparin / taurolidine Injection [Defencath]
SBDF · 2670466 -
Heparin sodium, porcine / taurolidine Injection [Defencath]
SBDFP · 2670467 -
Defencath Injectable Product
SBDG · 2670465 -
Defencath
BN · 2670463
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2670461 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 72990-0103-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (72990-103-10) / 3 mL in 1... | DEFENCATH | CorMedix Inc. | 2024-04-09 |
Observed labelers:
CorMedix Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.